Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...

Vision scientists received two federal grants totaling nearly $4 million from the National Eye Institute to support groundbreaking research aimed at better understanding the myopia epidemic and the ...